Medtronic Introduces Real-time Glucose Monitoring System

EHM News Bureau - Mumbai

Medtronic, India announced commercialisation of the Guardian RT Continuous Glucose Monitoring System in India for improved diabetes management. The system displays glucose readings every five minutes and alerts patients when glucose levels become too high or too low.

By seeing glucose values and hearing alarms, patients can intervene earlier to reduce the severity and duration of glucose fluctuations that can lead to diabetes-related complications, including coma, blindness, kidney failure, amputation, impotence and heart disease. The system uses a subcutaneous glucose sensor to record as many as 288 daily glucose readings – providing patients with nearly 100 times more information than three daily fingerstick readings provide.

The Guardian RT System is designed to provide real-time glucose readings throughout the day and night, allowing patients to understand how fast, and in what direction, their glucose levels are heading. By discovering how diet, exercise, medication and lifestyle affect their glucose levels, patients can make more informed decisions.